251 related articles for article (PubMed ID: 21548931)
1. Pathogenesis of Lassa fever in cynomolgus macaques.
Hensley LE; Smith MA; Geisbert JB; Fritz EA; Daddario-DiCaprio KM; Larsen T; Geisbert TW
Virol J; 2011 May; 8():205. PubMed ID: 21548931
[TBL] [Abstract][Full Text] [Related]
2. Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.
Rasmussen AL; Tchitchek N; Safronetz D; Carter VS; Williams CM; Haddock E; Korth MJ; Feldmann H; Katze MG
J Virol; 2015 Mar; 89(5):2543-52. PubMed ID: 25520505
[TBL] [Abstract][Full Text] [Related]
3. Immune-Mediated Systemic Vasculitis as the Proposed Cause of Sudden-Onset Sensorineural Hearing Loss following Lassa Virus Exposure in Cynomolgus Macaques.
Cashman KA; Wilkinson ER; Zeng X; Cardile AP; Facemire PR; Bell TM; Bearss JJ; Shaia CI; Schmaljohn CS
mBio; 2018 Oct; 9(5):. PubMed ID: 30377282
[TBL] [Abstract][Full Text] [Related]
4. An atlas of gross and histologic lesions and immunohistochemical immunoreactivity during the temporal progression of aerosolized Lassa virus induced hemorrhagic fever in cynomolgus macaques.
Bohler F; Cashman K; Wilkinson E; Johnson JC; Rosenke K; Shamblin J; Hensley L; Honko A; Shaia C
Front Cell Infect Microbiol; 2024; 14():1341891. PubMed ID: 38404292
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus.
Cross RW; Fenton KA; Woolsey C; Prasad AN; Borisevich V; Agans KN; Deer DJ; Dobias NS; Fears AC; Heinrich ML; Geisbert JB; Garry RF; Branco LM; Geisbert TW
Cell Rep Med; 2024 Feb; 5(2):101392. PubMed ID: 38280377
[TBL] [Abstract][Full Text] [Related]
6. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
[TBL] [Abstract][Full Text] [Related]
7. A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.
Safronetz D; Strong JE; Feldmann F; Haddock E; Sogoba N; Brining D; Geisbert TW; Scott DP; Feldmann H
J Infect Dis; 2013 Apr; 207(8):1316-27. PubMed ID: 23303805
[TBL] [Abstract][Full Text] [Related]
8. Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever.
Pannetier D; Reynard S; Russier M; Carnec X; Baize S
PLoS Negl Trop Dis; 2014; 8(1):e2637. PubMed ID: 24421914
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.
Lee AM; Cruite J; Welch MJ; Sullivan B; Oldstone MB
Virology; 2013 Aug; 442(2):114-21. PubMed ID: 23684417
[TBL] [Abstract][Full Text] [Related]
10. Temporal Progression of Lesions in Guinea Pigs Infected With Lassa Virus.
Bell TM; Shaia CI; Bearss JJ; Mattix ME; Koistinen KA; Honnold SP; Zeng X; Blancett CD; Donnelly GC; Shamblin JD; Wilkinson ER; Cashman KA
Vet Pathol; 2017 May; 54(3):549-562. PubMed ID: 28438110
[TBL] [Abstract][Full Text] [Related]
11. Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).
Liu DX; Perry DL; DeWald LE; Cai Y; Hagen KR; Cooper TK; Huzella LM; Hart R; Bonilla A; Bernbaum JG; Janosko KB; Adams R; Johnson RF; Kuhn JH; Schnell MJ; Crozier I; Jahrling PB; de la Torre JC
J Infect Dis; 2019 May; 219(11):1818-1822. PubMed ID: 30517671
[TBL] [Abstract][Full Text] [Related]
12. A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus.
Cross RW; Heinrich ML; Fenton KA; Borisevich V; Agans KN; Prasad AN; Woolsey C; Deer DJ; Dobias NS; Rowland MM; Lathigra R; Borrega R; Geisbert JB; Garry RF; Branco LM; Geisbert TW
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2304876120. PubMed ID: 37590417
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates.
Woolsey C; Cross RW; Prasad AN; Agans KN; Borisevich V; Deer DJ; Dobias NS; Fears AC; Harrison MB; Heinrich ML; Fenton KA; Garry RF; Branco LM; Geisbert TW
Emerg Microbes Infect; 2024 Dec; 13(1):2301061. PubMed ID: 38164768
[TBL] [Abstract][Full Text] [Related]
14. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.
Maruyama J; Manning JT; Mateer EJ; Sattler R; Bukreyeva N; Huang C; Paessler S
mSphere; 2019 Sep; 4(5):. PubMed ID: 31554720
[TBL] [Abstract][Full Text] [Related]
15. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.
Safronetz D; Sogoba N; Lopez JE; Maiga O; Dahlstrom E; Zivcec M; Feldmann F; Haddock E; Fischer RJ; Anderson JM; Munster VJ; Branco L; Garry R; Porcella SF; Schwan TG; Feldmann H
PLoS Negl Trop Dis; 2013; 7(12):e2582. PubMed ID: 24340119
[TBL] [Abstract][Full Text] [Related]
16. Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.
Baillet N; Reynard S; Perthame E; Hortion J; Journeaux A; Mateo M; Carnec X; Schaeffer J; Picard C; Barrot L; Barron S; Vallve A; Duthey A; Jacquot F; Boehringer C; Jouvion G; Pietrosemoli N; Legendre R; Dillies MA; Allan R; Legras-Lachuer C; Carbonnelle C; Raoul H; Baize S
Commun Biol; 2021 Jan; 4(1):27. PubMed ID: 33398113
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques.
Hensley LE; Alves DA; Geisbert JB; Fritz EA; Reed C; Larsen T; Geisbert TW
J Infect Dis; 2011 Nov; 204 Suppl 3():S1021-31. PubMed ID: 21987738
[TBL] [Abstract][Full Text] [Related]
18. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.
Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628
[TBL] [Abstract][Full Text] [Related]
19. Current research for a vaccine against Lassa hemorrhagic fever virus.
Warner BM; Safronetz D; Stein DR
Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
[TBL] [Abstract][Full Text] [Related]
20. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever.
Cross RW; Woolsey C; Prasad AN; Borisevich V; Agans KN; Deer DJ; Geisbert JB; Dobias NS; Fenton KA; Geisbert TW
Cell Rep; 2022 Jul; 40(3):111094. PubMed ID: 35858566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
